Drug that targets immune cells shows potential as new treatment for diabetic heart disease

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally intended, but by retraining the immune system to protect the heart from within.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup